THC–Morphine Cross-Tolerance Ran in Different Directions for Temperature and Antinociception in Mice

A 1978 mouse comparison found asymmetric cross-tolerance: prior THC reduced sensitivity to morphine hypothermia, while prior morphine reduced sensitivity to THC antinociception. A general two-way cross-tolerance label would conceal the endpoint distinction.

The drugs were compared under common conditions

Both drugs produced antinociception, hypothermia and increased catecholamine synthesis after subcutaneous administration. Their relative effects differed: morphine was more potent on the antinociceptive measure and increased dopamine synthesis more, while THC was more potent for cooling and increased norepinephrine synthesis more.

The cross-challenges were selective

THC-tolerant animals showed cross-tolerance only to morphine's hypothermic action in the reported comparison. Morphine-tolerant animals showed cross-tolerance only to THC antinociception. The observation did not establish equivalent protection across both drugs and both outcomes.

Antagonism was also incomplete

Naloxone partly antagonized THC-related hypothermia and catecholamine-synthesis increases. That supports investigating opioid-related interactions without establishing that THC's effects are mediated entirely through opioid receptors. Similar outward effects do not require identical primary pharmacology.

The study's strength is a matched species-and-strain comparison with several endpoints. It does not provide a dose conversion between THC and morphine or predict a patient's drug response. Exposure direction and measured function are necessary parts of any cross-tolerance claim.

Related: interpreting cannabis tolerance claims.

Research cited

Bloom AS; Dewey WL. A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse. Psychopharmacology (1978). doi:10.1007/BF00426745. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A 2026 Cannabis Review Explains Why Potency, Placebo Response and Sedation Need Separate Measures

A 2026 narrative review argues that product potency is not the same as delivered THC dose and that placebo responses remain important among experienced users. Its laboratory framework also distinguishes reduced drug reinforcement from nonspecific sedation. Users can change how they inhale The review notes that participants alter inhalation patterns…

Spread the love

Read Article: A 2026 Cannabis Review Explains Why Potency, Placebo Response and Sedation Need Separate Measures

THC Antinociception Persisted Without the Same Dynorphin Signal in Tolerant Rats

A 1999 rat study found that tolerance weakened THC-related modulation of spinal dynorphin, while antinociception could still occur without the same elevated dynorphin measure. The role of a downstream signal changed with dose and adaptive state. The experiment examined spinal responses The work followed earlier findings linking acute intrathecal THC…

Spread the love

Read Article: THC Antinociception Persisted Without the Same Dynorphin Signal in Tolerant Rats

A Passiflora-Derived Fraction Reduced THC Withdrawal Signs in a Mouse Model

A 2002 mouse experiment reported fewer antagonist-precipitated withdrawal signs with a Passiflora-derived benzoflavone fraction. The finding concerns a defined experimental preparation and animal model, not a demonstrated treatment for cannabis-use disorder in people. Concurrent and acute interventions were tested Mice received repeated oral THC with or without the fraction. A…

Spread the love

Read Article: A Passiflora-Derived Fraction Reduced THC Withdrawal Signs in a Mouse Model

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us